Mantle cell lymphoma patients in first relapse: we pretty much know what to do
Oncotarget
.
2021 Aug 17;12(17):1724-1726.
doi: 10.18632/oncotarget.27980.
Authors
Francesca Maria Quaglia
,
Carlo Visco
PMID:
34434500
PMCID:
PMC8378770
DOI:
10.18632/oncotarget.27980
No abstract available
Keywords:
POD; ibrutinib; mantle cell lymphoma; relapsed-refractory MCL; treatment algorithm.
Publication types
Editorial